BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33405231)

  • 1. Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma.
    Shanmugam A; Hariharan AK; Hasina R; Nair JR; Katragadda S; Irusappan S; Ravichandran A; Veeramachaneni V; Bettadapura R; Bhati M; Ramaswamy V; Rao VUS; Bagadia RK; Manjunath A; Manjunath NML; Solomon MC; Maji S; Bahadur U; Bettegowda C; Papadopoulos N; Lingen MW; Hariharan R; Gupta V; Agrawal N; Izumchenko E
    Cancer; 2021 May; 127(10):1576-1589. PubMed ID: 33405231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the contribution of smoking and HPV towards the etiology of oral cavity squamous cell carcinoma using high-throughput sequencing: A prospective observational study.
    Zammit AP; Sinha R; Cooper CL; Perry CFL; Frazer IH; Tuong ZK
    PLoS One; 2018; 13(10):e0205406. PubMed ID: 30308005
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Krüger K; Grust A; Muallah D; Patenge A; Wikman H; Mesa MM; Knust ES; Sartori A; Smeets R; Kluwe L; Friedrich RE; Burg S
    Anticancer Res; 2024 Jun; 44(6):2369-2376. PubMed ID: 38821622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The implications of gene mutations in salivary DNA for noninvasive diagnosis of head and neck cancer with a focus on oral cancer.
    Yang X; Song H; Ji T; Du G; Liu W
    Oral Oncol; 2022 Jul; 130():105924. PubMed ID: 35594773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas.
    Cui Y; Kim HS; Cho ES; Han D; Park JA; Park JY; Nam W; Kim HJ; Cha IH; Cha YH
    PLoS One; 2021; 16(9):e0256979. PubMed ID: 34478472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma.
    Hanna GJ; Woo SB; Li YY; Barletta JA; Hammerman PS; Lorch JH
    Int J Oral Maxillofac Surg; 2018 May; 47(5):568-577. PubMed ID: 28969885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary transcriptome diagnostics for oral cancer detection.
    Li Y; St John MA; Zhou X; Kim Y; Sinha U; Jordan RC; Eisele D; Abemayor E; Elashoff D; Park NH; Wong DT
    Clin Cancer Res; 2004 Dec; 10(24):8442-50. PubMed ID: 15623624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma.
    Liao CT; Yang LY; Lee LY; Lin CY; Wang HM; Ng SH; Yen TC; Fan WL; Hsieh JC
    Oral Oncol; 2021 Nov; 122():105547. PubMed ID: 34700279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.
    Saito Y; Kage H; Kobayashi K; Yoshida M; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
    Head Neck; 2023 Dec; 45(12):3107-3118. PubMed ID: 37815002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva.
    Guerrero-Preston R; Soudry E; Acero J; Orera M; Moreno-López L; Macía-Colón G; Jaffe A; Berdasco M; Ili-Gangas C; Brebi-Mieville P; Fu Y; Engstrom C; Irizarry RA; Esteller M; Westra W; Koch W; Califano J; Sidransky D
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1061-72. PubMed ID: 21558411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of seven RNA binding protein genes as a prognostic signature in oral cavity squamous cell carcinoma.
    Huang Z; Lan T; Wang J; Chen Z; Zhang X
    Bioengineered; 2021 Dec; 12(1):7248-7262. PubMed ID: 34585646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma.
    Nakagaki T; Tamura M; Kobashi K; Omori A; Koyama R; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
    Tumour Biol; 2018 Sep; 40(9):1010428318800180. PubMed ID: 30226113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation detection in saliva from oral cancer patients.
    Ahmed AA; Sborchia M; Bye H; Roman-Escorza M; Amar A; Henley-Smith R; Odell E; McGurk M; Simpson M; Ng T; Sawyer EJ; Mathew CG
    Oral Oncol; 2024 Apr; 151():106717. PubMed ID: 38412584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
    St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
    Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
    Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma.
    Nagata S; Hamada T; Yamada N; Yokoyama S; Kitamoto S; Kanmura Y; Nomura M; Kamikawa Y; Yonezawa S; Sugihara K
    Cancer; 2012 Sep; 118(17):4298-308. PubMed ID: 22252571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas.
    Liao PH; Chang YC; Huang MF; Tai KW; Chou MY
    Oral Oncol; 2000 May; 36(3):272-6. PubMed ID: 10793330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
    Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
    Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.